SK286160B6 - Použitie dexmedetomidínu na výrobu liečiva - Google Patents

Použitie dexmedetomidínu na výrobu liečiva Download PDF

Info

Publication number
SK286160B6
SK286160B6 SK1436-2000A SK14362000A SK286160B6 SK 286160 B6 SK286160 B6 SK 286160B6 SK 14362000 A SK14362000 A SK 14362000A SK 286160 B6 SK286160 B6 SK 286160B6
Authority
SK
Slovakia
Prior art keywords
dexmedetomidine
patient
sedation
patients
icu
Prior art date
Application number
SK1436-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK14362000A3 (sk
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corporation
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK286160(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation, Abbott Laboratories filed Critical Orion Corporation
Publication of SK14362000A3 publication Critical patent/SK14362000A3/sk
Publication of SK286160B6 publication Critical patent/SK286160B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1436-2000A 1998-04-01 1999-03-31 Použitie dexmedetomidínu na výrobu liečiva SK286160B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (2)

Publication Number Publication Date
SK14362000A3 SK14362000A3 (sk) 2002-03-05
SK286160B6 true SK286160B6 (sk) 2008-04-07

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1436-2000A SK286160B6 (sk) 1998-04-01 1999-03-31 Použitie dexmedetomidínu na výrobu liečiva

Country Status (27)

Country Link
EP (1) EP1069893B1 (zh)
JP (1) JP4606581B2 (zh)
KR (1) KR20010034728A (zh)
CN (1) CN1168441C (zh)
AR (1) AR015744A1 (zh)
AT (1) ATE347359T1 (zh)
AU (1) AU754484B2 (zh)
BG (1) BG64540B1 (zh)
BR (1) BR9909872A (zh)
CA (1) CA2326339C (zh)
CZ (1) CZ301013B6 (zh)
DE (1) DE69934305T2 (zh)
DK (1) DK1069893T3 (zh)
EA (1) EA005524B1 (zh)
ES (1) ES2278441T3 (zh)
GB (1) GB2352972B (zh)
HU (1) HU229162B1 (zh)
IL (1) IL138416A (zh)
NO (1) NO329194B1 (zh)
NZ (1) NZ507203A (zh)
PL (1) PL192517B1 (zh)
PT (1) PT1069893E (zh)
SI (1) SI1069893T1 (zh)
SK (1) SK286160B6 (zh)
TR (1) TR200002837T2 (zh)
TW (1) TW552136B (zh)
WO (1) WO1999049854A2 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030347A1 (en) 1999-10-29 2001-05-03 Orion Corporation Treatment or prevention of hypotension and shock
RU2297216C2 (ru) * 2002-04-08 2007-04-20 Эм-Джи-Ай Джи-Пи,Инк. Фармацевтические композиции, содержащие растворимые в воде пролекарства пропофола, и способы их применения
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
DK2244737T3 (da) 2008-01-22 2019-07-08 Univ Texas Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
KR101859486B1 (ko) * 2009-05-15 2018-06-28 레크로파마, 인코포레이티드 설하용 덱스메데토미딘 조성물과 그의 사용 방법
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
AU2012352528B9 (en) 2011-12-11 2017-11-02 Baudax Bio, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
NZ706990A (en) * 2012-10-15 2017-12-22 Orion Corp A veterinary method of alleviating noise aversion
CN105473669A (zh) 2013-07-24 2016-04-06 I-技术有限公司 作为抑制剂的对映异构体左旋美托咪啶在海洋生物污损表面附着的应用
US10772871B2 (en) 2013-10-07 2020-09-15 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
EP3054930B1 (en) 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
CN1295473A (zh) 2001-05-16
CA2326339C (en) 2008-12-23
DE69934305D1 (de) 2007-01-18
ES2278441T3 (es) 2007-08-01
CZ20003484A3 (cs) 2002-01-16
WO1999049854A3 (en) 1999-11-18
CZ301013B6 (cs) 2009-10-14
PT1069893E (pt) 2007-01-31
TW552136B (en) 2003-09-11
BG64540B1 (bg) 2005-07-29
PL343553A1 (en) 2001-08-27
CN1168441C (zh) 2004-09-29
AR015744A1 (es) 2001-05-16
DK1069893T3 (da) 2007-03-19
WO1999049854A2 (en) 1999-10-07
GB0024932D0 (en) 2000-11-29
IL138416A (en) 2005-07-25
NO20004931L (no) 2000-09-29
AU3149499A (en) 1999-10-18
TR200002837T2 (tr) 2001-01-22
NO20004931D0 (no) 2000-09-29
BG104797A (en) 2001-07-31
ATE347359T1 (de) 2006-12-15
SI1069893T1 (sl) 2007-04-30
NZ507203A (en) 2003-03-28
PL192517B1 (pl) 2006-10-31
IL138416A0 (en) 2001-10-31
CA2326339A1 (en) 1999-10-07
SK14362000A3 (sk) 2002-03-05
EP1069893A2 (en) 2001-01-24
JP2002509880A (ja) 2002-04-02
GB2352972B (en) 2003-05-21
DE69934305T2 (de) 2007-07-12
EA200001010A1 (ru) 2001-02-26
KR20010034728A (ko) 2001-04-25
NO329194B1 (no) 2010-09-13
BR9909872A (pt) 2007-11-20
JP4606581B2 (ja) 2011-01-05
HU229162B1 (hu) 2013-09-30
HUP0101498A1 (hu) 2002-03-28
EA005524B1 (ru) 2005-04-28
AU754484B2 (en) 2002-11-14
HUP0101498A3 (en) 2002-06-28
EP1069893B1 (en) 2006-12-06
GB2352972A (en) 2001-02-14

Similar Documents

Publication Publication Date Title
SK286160B6 (sk) Použitie dexmedetomidínu na výrobu liečiva
US6716867B1 (en) Use of dexmedetomidine for ICU sedation
Raval et al. Oral clonidine pre medication for attenuation of haemodynamic response to laryngoscopy and intubation
Smiley et al. Dexmedetomidine sedation with and without midazolam for third molar surgery
Guglielminotti et al. Effects of premedication on dose requirements for propofol: comparison of clonidine and hydroxyzine.
Adachi et al. Small dose midazolam or droperidol reduces the hypnotic dose of propofol at the induction of anaesthesia
Dyson Analgesia and chemical restraint for the emergent veterinary patient
Mikati et al. Anesthetic implications in alternating hemiplegia of childhood: A case report
Pekcan How can better anaesthetic combinations be performed? A review of current knowledge
Kecik et al. A case of acute poisoning due to organophosphate insecticide
Ramya A Comparative Study Of Dexmedetomidine Versus Midazolam For Monitored Anaesthesia Care In Middle Ear Surgeries
Pathmanathan 10 Sedation and delirium
Tryba Alpha2-adrenoceptor agonists in intensive care medicine: Prevention and treatment of withdrawal
Mamatha Comparative Study Between Dexmedetomidine and Midazolam in Inducing Conscious Sedation in Patient Undergoing Cataract Surgery
Marviya et al. Role of dexmedetomidine infusion on post operative emergence agitation and quality of recovery after nasal surgery: A prospective randomized double blind controlled trial
FRH Comparison of Intrathecal Dexmedetomidine and Buprenorphine as Adjuvant to Bupivacaine for Lower Limb Surgeries
Sehrawat et al. Clonidine Infusion as Premedication in Hypertensive Patients: A Randomised Controlled Study
Awasthi et al. A comparison among different doses of dexmedetomidine in attenuating extubation response in patients undergoing open cholecystectomy
Duda The good, bad, and ugly: Using ketamine for ED pediatric patients
Álvarez-Juárez Adjuvant Drugs to Decrease the Adrenergic Response in Conventional Laryngoscopy
WO2008043211A1 (fr) Utilisation de la kétansérine pour la préparation de médicaments prévenant l'apoplexie cérébrale
Gupta Comparison of Dexmedetomidine, Propofol and Midazolam for Sedation in Intensive Care Unit
Reddy et al. Effect of oral Clonidine premedication before anaesthesia: Double blindprospective randomized study.
Evans Dexmedetomidine and Pediatric Emergence Agitation.
Siddiqui Efficacy of nalbuphine pre-treatment in attenuation of etomidate induced myoclonus: A placebo controlled trial from Malwa region

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: ORION CORPORATION, ESPOO, FI

Free format text: FORMER OWNER: ORION CORPORATION, ESPOO, FI; ABBOTT LABORATORIES, ABBOTT PARK, IL, US

Effective date: 20161111

MK4A Expiry of patent

Expiry date: 20190331